Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing ...
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new ...
PMLive1d
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B
Sanofi’s Qfitlia (fitusiran) has been approved by the US Food and Drug Administration (FDA) as the first therapy to treat ...
Medindia6d
Yoda Therapeutics Announces First Patient Dosed in Phase 2 Trial of YA-101 for Multiple System Atrophy
Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...
Blueprint Medicines: Strong Business, Ambitious Targets, Expensive Stock
Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...
Medera Presented Updated Results From First-In-Human Gene Therapy Trial For Heart Failure With Preserved Ejection Fraction At 2025 Hfpef Summit
The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...
TMCnet3d
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the ...
The Manila Times1d
CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
CorVista Health today announced a poster presentation showcasing preliminary results of its machine learning-based algorithm ...
Finanznachrichten2d
Poxel SA: Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Chief Executive Officer of Poxel. "With a significant number of type-2 diabetes patients also affected by renal impairment, the ability to offer a safe and effective treatment option is critical.
Poor blood flow in the brain linked to postural orthostatic tachycardia syndrome
In what is believed to be a world-first study, researchers from the University of Adelaide's Australian Dysautonomia and ...
Aaron Glenn has a plan to fix the Jets’ culture — it starts with silence
The Jets have tried various styles of head coach — the players’ coach (Robert Saleh), the offensive innovator (Adam Gase), the defensive stalwart (Todd Bowles), the rah-rah disciplinarian (Rex Ryan).